Fundraising FoxCodetta Bio
Morrisville, US · Founded 2021 · Delaware corporation · 3 known investors
Find your way into Codetta Bio
Sign up to see every warm intro you have to Codetta Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Codetta Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample. Its tools serve multi-omics research and life sciences applications.
Founders & leadership
Codetta Bio was founded in 2021 by Michael Ramsey.
MR
Michael RamseyCo-Founder
JC
Jacques CorriveauPresident and CEOJacques Corriveau has over 25 years of experience in biopharma and diagnostics, with roles spanning commercial strategy, operations, and go-to-market development for genomics and cell-based platforms. He is Executive Officer and Director at Codetta Bio.
WH
William Hampton HenleyExecutive
Board
JH
Investors · 3
Anzu Partnerslisted by Anzu PartnersBillerica
How we know: Anzu Partners's portfolio page · a partner's Signal profile · Not right? Tell us
Bantam Grouplisted by Bantam GroupWestwood
How we know: the VCSheet dataset · Not right? Tell us
Genoa Ventureslisted by Genoa VenturesSan Francisco
How we know: Genoa Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$12.3M disclosed across 1 round · 2024
▶$12.3MraisedOct 2024 · 4 investors · BiotechnologyRule 506(b)
▶$12.3MraisedOct 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jacques CorriveauExecutive Officer, Director
- William Hampton HenleyExecutive Officer
- John HoDirector
- J. Michael RamseyDirector
- Offering amount
- $26.4M
- Amount sold
- $12.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Codetta Bio went on to found or lead other companies.
Related companies · 9
ConcertoConcerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
Synata BioSynata Bio develops customizable technology solutions for hydrogen and carbon economies, enabling hard-to-abate industries to achieve decarbonization targets while reducing carbon emissions and creating value from waste resources.
Taconic BiosciencesTaconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.
Ditto BiosciencesDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
OctaveOctave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.
TagbioTag.bio offers a data platform for the healthcare and life sciences industry, using data mesh architectures and AI-powered analytics to manage large, complex datasets and speed up data analysis. It targets organizations working with sensitive, high-volume biomedical and healthcare data.
Predicta BiosciencesPredicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.
Vedanta BiosciencesVedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection. Its oral therapies target gut dysbiosis-driven conditions.
Companies working in the same space as Codetta Bio.
Frequently asked questions
- What does Codetta Bio do?
- Codetta Bio develops multiplex biomarker detection technology that combines digital PCR, real-time PCR, and immunoPCR with microbead-based target capture to simultaneously measure proteins, DNA, and RNA from a single sample. Its tools serve multi-omics research and life sciences applications.
- Who founded Codetta Bio?
- Codetta Bio was founded by Michael Ramsey in 2021.
- Who are Codetta Bio's investors?
- Codetta Bio's investors include Anzu Partners, Bantam Group, Genoa Ventures.
- How much funding has Codetta Bio raised?
- Codetta Bio has disclosed $12.3M raised across 1 round.
- Where is Codetta Bio headquartered?
- Codetta Bio is headquartered in Morrisville, US.